Chemoinformaics analysis of 5-Methylhexanenitrile 5-Methylhexanenitrile
| Molecular Weight | 111.188 | nRot | 3 |
| Heavy Atom Molecular Weight | 98.084 | nRig | 18 |
| Exact Molecular Weight | 111.105 | nRing | 0 |
| Solubility: LogS | -3.787 | nHRing | 0 |
| Solubility: LogP | 2.949 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 21.4583 |
| nHD | 0 | BPOL | 13.6117 |
| QED | 0.772 |
| Synth | 2.141 |
| Natural Product Likeliness | 0.881 |
| NR-PPAR-gamma | 0.901 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.777 |
| Pgp-sub | 0.01 |
| HIA | 0.009 |
| CACO-2 | -4.766 |
| MDCK | 0.0000187 |
| BBB | 0.014 |
| PPB | 0.935466 |
| VDSS | 0.69 |
| FU | 0.0872902 |
| CYP1A2-inh | 0.839 |
| CYP1A2-sub | 0.946 |
| CYP2c19-inh | 0.575 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.671 |
| CYP2c9-sub | 0.856 |
| CYP2d6-inh | 0.42 |
| CYP2d6-sub | 0.72 |
| CYP3a4-inh | 0.639 |
| CYP3a4-sub | 0.241 |
| CL | 6.095 |
| T12 | 0.883 |
| hERG | 0.043 |
| Ames | 0.362 |
| ROA | 0.148 |
| SkinSen | 0.368 |
| Carcinogencity | 0.118 |
| EI | 0.554 |
| Respiratory | 0.144 |
| NR-Aromatase | 0.892 |
| Antiviral | No |
| Prediction | 0.956067 |